Andrew Huberman with Dr. Abud Bakri
BPC-157’s animal results do not settle whether a pill or an injection will work in people. The same uncertainty sits behind much of the peptide market.
Peptides can be grouped by whether they act through known cell receptors or through broader, less clearly defined effects on proteins and gene regulation.
BPC-157 supports tissue repair in animal models; Dr. Bakri proposes gut-brain effects, but human reports remain anecdotal, and sparse pharmacokinetic data make oral versus local injection outcomes hard to predict.
The thymus declines rapidly after puberty, reducing new T-cell production and making thymus-derived peptides a potential target for supporting immune function.